NBI components
The NASDAQ Biotechnology constituents can be found in the table below. Sort NBI stock components by various financial metrics and data such as performance, dividends, income statement and balance sheet.
Symbol | Market cap | Price | Change % | Volume | Rel Volume | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst Rating |
|---|---|---|---|---|---|---|---|---|---|---|---|
 AZNAstraZeneca PLCDR | 217.03 B USD | 69.74 USD | +0.09% | 2.59 M | 0.68 | 28.02 | 2.49 USD | +22.68% | 2.18% | Health technology | Strong buy |
 AMGNAmgen Inc. | 150.53 B USD | 279.94 USD | −0.15% | 1.03 M | 0.32 | 25.55 | 10.95 USD | +56.65% | 3.30% | Health technology | Buy |
 GILDGilead Sciences, Inc. | 133.2 B USD | 107.08 USD | +1.09% | 2.01 M | 0.22 | 22.52 | 4.76 USD | +1,225.82% | 2.93% | Health technology | Buy |
 SNYSanofiDR | 116.92 B USD | 48.22 USD | +0.88% | 1.15 M | 0.48 | 20.14 | 2.39 USD | +3.07% | 3.34% | Health technology | Buy |
 VRTXVertex Pharmaceuticals Incorporated | 113.59 B USD | 442.34 USD | −0.78% | 560.32 K | 0.46 | — | −3.92 USD | −125.45% | 0.00% | Health technology | Buy |
 REGNRegeneron Pharmaceuticals, Inc. | 56.12 B USD | 519.81 USD | −0.09% | 472.96 K | 0.44 | 13.23 | 39.29 USD | +16.05% | 0.34% | Health technology | Buy |
 ALNYAlnylam Pharmaceuticals, Inc. | 41.2 B USD | 315.97 USD | −1.85% | 271.92 K | 0.37 | — | −2.09 USD | +21.99% | 0.00% | Health technology | Buy |
 ARGXargenx SEDR | 34.38 B USD | 557.82 USD | −0.48% | 93.83 K | 0.28 | 43.73 | 12.76 USD | — | 0.00% | Health technology | Strong buy |
 ONCBeOne Medicines Ltd.DR | 33.69 B USD | 257.43 USD | −3.63% | 165.53 K | 0.43 | — | −3.71 USD | +50.93% | 0.00% | Health technology | Strong buy |
 BNTXBioNTech SEDR | 25.19 B USD | 106.22 USD | +1.35% | 210.37 K | 0.24 | — | −3.44 USD | −817.67% | 0.00% | Health technology | Buy |
 RPRXRoyalty Pharma plc | 19.9 B USD | 35.39 USD | −1.46% | 1.14 M | 0.22 | 14.43 | 2.45 USD | +37.66% | 2.39% | Health technology | Buy |
 INSMInsmed Incorporated | 19.41 B USD | 102.18 USD | −2.55% | 1.89 M | 0.37 | — | −5.95 USD | −13.60% | 0.00% | Health technology | Strong buy |
 BIIBBiogen Inc. | 18.64 B USD | 127.20 USD | −0.09% | 276.42 K | 0.20 | 12.56 | 10.13 USD | +26.48% | 0.00% | Health technology | Buy |
 SMMTSummit Therapeutics Inc. | 15.74 B USD | 21.20 USD | −0.35% | 609.39 K | 0.19 | — | −0.33 USD | −99.70% | 0.00% | Health technology | Strong buy |
 ILMNIllumina, Inc. | 14.95 B USD | 94.45 USD | +1.31% | 1.23 M | 0.53 | — | −6.10 USD | +25.12% | 0.00% | Health technology | Buy |
 INCYIncyte Corporation | 13.74 B USD | 70.99 USD | +5.09% | 1.66 M | 0.89 | 219.65 | 0.32 USD | −90.19% | 0.00% | Health technology | Buy |
 UTHRUnited Therapeutics Corporation | 12.86 B USD | 285.15 USD | −0.29% | 150.36 K | 0.19 | 11.38 | 25.06 USD | +18.48% | 0.00% | Health technology | Buy |
 GMABGenmab A/SDR | 12.61 B USD | 20.71 USD | +0.93% | 291.13 K | 0.14 | 11.75 | 1.76 USD | +46.17% | 0.00% | Health technology | Buy |
 NBIXNeurocrine Biosciences, Inc. | 12.55 B USD | 126.77 USD | −0.79% | 152.83 K | 0.17 | 42.99 | 2.95 USD | −18.93% | 0.00% | Health technology | Strong buy |
 TEMTempus AI, Inc. | 11.88 B USD | 68.63 USD | +4.83% | 5.48 M | 0.53 | — | −4.60 USD | −160.27% | 0.00% | Technology services | Buy |
 EXELExelixis, Inc. | 11.77 B USD | 43.17 USD | −0.83% | 1.05 M | 0.25 | 19.59 | 2.20 USD | +240.89% | 0.00% | Health technology | Buy |
 MRNAModerna, Inc. | 10.89 B USD | 28.16 USD | +4.82% | 5.93 M | 0.69 | — | −8.72 USD | +44.36% | 0.00% | Health technology | Neutral |
 VTRSViatris Inc. | 10.65 B USD | 9.07 USD | +2.02% | 4.87 M | 0.43 | — | −3.18 USD | −6,283.33% | 5.40% | Health technology | Neutral |
 ASNDAscendis Pharma A/SDR | 10.44 B USD | 174.28 USD | +0.74% | 128.26 K | 0.33 | — | −6.29 USD | +34.71% | 0.00% | Health technology | Strong buy |
 BMRNBioMarin Pharmaceutical Inc. | 10.35 B USD | 53.99 USD | −0.28% | 497.49 K | 0.23 | 20.03 | 2.70 USD | +152.22% | 0.00% | Health technology | Buy |
 MEDPMedpace Holdings, Inc. | 8.86 B USD | 308.17 USD | −0.95% | 149.75 K | 0.31 | 23.52 | 13.10 USD | +33.50% | 0.00% | Commercial services | Neutral |
 BBIOBridgeBio Pharma, Inc. | 8.42 B USD | 44.34 USD | −0.09% | 909.19 K | 0.29 | — | −3.53 USD | −9.37% | 0.00% | Health technology | Strong buy |
 BPMCBlueprint Medicines Corporation | 8.29 B USD | 128.17 USD | −0.06% | 1.33 M | 0.34 | — | −2.46 USD | +48.96% | 0.00% | Health technology | Neutral |
 VRNAVerona Pharma plcDR | 8.1 B USD | 93.94 USD | −1.23% | 366.2 K | 0.29 | — | −2.04 USD | −157.53% | 0.00% | Health technology | Strong buy |
 ROIVRoivant Sciences Ltd. | 7.79 B USD | 11.46 USD | +0.53% | 2.94 M | 0.41 | — | −0.25 USD | −104.91% | 0.00% | Health technology | Strong buy |
 GRFSGrifols, S.A.DR | 7.09 B USD | 8.74 USD | +2.76% | 242.3 K | 0.31 | 28.43 | 0.31 USD | +1.92% | 0.00% | Health technology | Neutral |
 RVMDRevolution Medicines, Inc. | 6.95 B USD | 37.29 USD | −2.92% | 869.13 K | 0.43 | — | −4.00 USD | −6.30% | 0.00% | Health technology | Strong buy |
 MDGLMadrigal Pharmaceuticals, Inc. | 6.58 B USD | 296.37 USD | +6.75% | 265.91 K | 0.87 | — | −18.04 USD | +21.83% | 0.00% | Health technology | Strong buy |
 JAZZJazz Pharmaceuticals plc | 6.51 B USD | 107.64 USD | +0.49% | 225.19 K | 0.33 | 14.52 | 7.42 USD | +61.30% | 0.00% | Health technology | Strong buy |
 HALOHalozyme Therapeutics, Inc. | 6.47 B USD | 52.47 USD | +0.29% | 868.72 K | 0.44 | 13.92 | 3.77 USD | +55.89% | 0.00% | Health technology | Buy |
 IONSIonis Pharmaceuticals, Inc. | 6.39 B USD | 40.14 USD | +0.35% | 632.85 K | 0.34 | — | −2.98 USD | −11.81% | 0.00% | Health technology | Buy |
 LEGNLegend Biotech CorporationDR | 6.15 B USD | 32.97 USD | −1.38% | 429.44 K | 0.22 | — | −1.19 USD | +54.33% | 0.00% | Health technology | Strong buy |
 GHGuardant Health, Inc. | 6.09 B USD | 49.12 USD | −1.56% | 808.92 K | 0.40 | — | −3.38 USD | +13.87% | 0.00% | Health services | Buy |
 NUVLNuvalent, Inc. | 5.64 B USD | 78.49 USD | −0.76% | 176.68 K | 0.37 | — | −4.40 USD | −82.61% | 0.00% | Health technology | Strong buy |
 AXSMAxsome Therapeutics, Inc. | 5.06 B USD | 102.70 USD | −0.96% | 168.02 K | 0.25 | — | −5.77 USD | +9.65% | 0.00% | Health technology | Strong buy |
 ALKSAlkermes plc | 4.78 B USD | 28.96 USD | +0.21% | 537.24 K | 0.28 | 13.79 | 2.10 USD | −17.17% | 0.00% | Health technology | Buy |
 AKROAkero Therapeutics, Inc. | 4.43 B USD | 55.62 USD | +1.04% | 326.13 K | 0.18 | — | −3.75 USD | −17.04% | 0.00% | Health technology | Strong buy |
 ADMAADMA Biologics Inc | 4.33 B USD | 18.14 USD | +3.07% | 1.01 M | 0.24 | 21.49 | 0.84 USD | — | 0.00% | Health technology | Buy |
 PCVXVaxcyte, Inc. | 4.19 B USD | 32.51 USD | −1.75% | 611.45 K | 0.52 | — | −4.07 USD | +6.64% | 0.00% | Health technology | Strong buy |
 ZLABZai Lab LimitedDR | 4.16 B USD | 36.10 USD | −2.31% | 268.75 K | 0.26 | — | −2.50 USD | +28.63% | 0.00% | Health technology | Strong buy |
 KRYSKrystal Biotech, Inc. | 4.11 B USD | 142.08 USD | −0.29% | 144.22 K | 0.31 | 34.22 | 4.15 USD | +120.59% | 0.00% | Health technology | Strong buy |
 CRSPCRISPR Therapeutics AG | 4.06 B USD | 46.97 USD | −1.45% | 1.34 M | 0.50 | — | −4.52 USD | −65.91% | 0.00% | Health technology | Buy |
 MRUSMerus N.V. | 4.02 B USD | 54.04 USD | +0.29% | 168.61 K | 0.18 | — | −4.12 USD | −51.27% | 0.00% | Health technology | Strong buy |
 CYTKCytokinetics, Incorporated | 4.01 B USD | 33.57 USD | +1.39% | 415.33 K | 0.29 | — | −5.31 USD | +1.75% | 0.00% | Health technology | Strong buy |
 PTCTPTC Therapeutics, Inc. | 3.9 B USD | 49.24 USD | +0.72% | 163.69 K | 0.14 | 7.56 | 6.51 USD | — | 0.00% | Health technology | Buy |
 RYTMRhythm Pharmaceuticals, Inc. | 3.89 B USD | 61.09 USD | −1.93% | 258.68 K | 0.47 | — | −2.82 USD | +39.30% | 0.00% | Health technology | Strong buy |
 ACADACADIA Pharmaceuticals Inc. | 3.74 B USD | 22.36 USD | −0.62% | 926.09 K | 0.44 | 16.28 | 1.37 USD | — | 0.00% | Health technology | Buy |
 RNAAvidity Biosciences, Inc. | 3.54 B USD | 29.38 USD | −1.74% | 262.34 K | 0.20 | — | −3.01 USD | −1.89% | 0.00% | Health technology | Strong buy |
 ACLXArcellx, Inc. | 3.51 B USD | 63.64 USD | −0.61% | 210.94 K | 0.39 | — | −2.98 USD | −180.15% | 0.00% | Health technology | Strong buy |
 RAREUltragenyx Pharmaceutical Inc. | 3.5 B USD | 36.99 USD | −1.19% | 241.09 K | 0.23 | — | −5.88 USD | +26.72% | 0.00% | Health technology | Strong buy |
 PTGXProtagonist Therapeutics, Inc. | 3.36 B USD | 54.25 USD | −0.35% | 351.3 K | 0.36 | 71.32 | 0.76 USD | −68.94% | 0.00% | Health technology | Strong buy |
 SRRKScholar Rock Holding Corporation | 3.31 B USD | 34.91 USD | −2.53% | 434.94 K | 0.24 | — | −2.65 USD | −20.30% | 0.00% | Health technology | Strong buy |
 KYMRKymera Therapeutics, Inc. | 2.99 B USD | 45.93 USD | −1.16% | 740.9 K | 1.23 | — | −3.10 USD | −23.89% | 0.00% | Health technology | Strong buy |
 ALVOAlvotech | 2.85 B USD | 9.45 USD | +3.50% | 95.91 K | 0.53 | 28.02 | 0.34 USD | — | 0.00% | Health technology | Buy |
 CRNXCrinetics Pharmaceuticals, Inc. | 2.8 B USD | 29.87 USD | −1.78% | 195.56 K | 0.35 | — | −3.82 USD | −1.20% | 0.00% | Health technology | Strong buy |
 IMVTImmunovant, Inc. | 2.76 B USD | 16.17 USD | +2.67% | 357.35 K | 0.25 | — | −2.74 USD | −44.95% | 0.00% | Health technology | Strong buy |
 HCMHUTCHMED (China) LimitedDR | 2.74 B USD | 15.24 USD | −1.55% | 5.21 K | 0.06 | 70.52 | 0.22 USD | −62.40% | 0.00% | Health technology | Strong buy |
 APGEApogee Therapeutics, Inc. | 2.55 B USD | 42.76 USD | −0.54% | 192.59 K | 0.23 | — | −3.54 USD | −72.82% | 0.00% | Health technology | Strong buy |
 AMRXAmneal Pharmaceuticals, Inc. | 2.54 B USD | 8.12 USD | +0.81% | 701.93 K | 0.37 | — | −0.04 USD | +92.15% | 0.00% | Health technology | Strong buy |
 MIRMMirum Pharmaceuticals, Inc. | 2.49 B USD | 50.31 USD | +0.35% | 84.32 K | 0.18 | — | −1.61 USD | +57.12% | 0.00% | Health technology | Strong buy |
 IBRXImmunityBio, Inc. | 2.45 B USD | 2.78 USD | +0.72% | 1.89 M | 0.23 | — | −0.58 USD | +44.53% | 0.00% | Health technology | Strong buy |
 XENEXenon Pharmaceuticals Inc. | 2.42 B USD | 31.59 USD | −0.54% | 195.32 K | 0.23 | — | −3.22 USD | −18.58% | 0.00% | Health technology | Strong buy |
 APLSApellis Pharmaceuticals, Inc. | 2.3 B USD | 18.31 USD | −0.44% | 294.39 K | 0.17 | — | −1.79 USD | +48.16% | 0.00% | Health technology | Buy |
 LGNDLigand Pharmaceuticals Incorporated | 2.21 B USD | 114.44 USD | −1.11% | 46.41 K | 0.33 | — | −7.12 USD | −233.81% | 0.00% | Health technology | Strong buy |
 TWSTTwist Bioscience Corporation | 2.2 B USD | 36.71 USD | −0.76% | 276.05 K | 0.27 | — | −3.26 USD | +2.75% | 0.00% | Health technology | Buy |
 ARWRArrowhead Pharmaceuticals, Inc. | 2.15 B USD | 15.58 USD | −0.51% | 335.18 K | 0.22 | — | −1.38 USD | +67.48% | 0.00% | Health technology | Buy |
 RXRXRecursion Pharmaceuticals, Inc. | 2.15 B USD | 5.29 USD | +2.52% | 12.63 M | 0.45 | — | −1.78 USD | −11.00% | 0.00% | Health technology | Buy |
 DNLIDenali Therapeutics Inc. | 2.08 B USD | 14.29 USD | −1.11% | 370.93 K | 0.26 | — | −2.67 USD | −176.38% | 0.00% | Health technology | Strong buy |
 VCELVericel Corporation | 2.07 B USD | 41.06 USD | −1.96% | 130.09 K | 0.32 | 1,039.49 | 0.04 USD | — | 0.00% | Health technology | Strong buy |
 VCYTVeracyte, Inc. | 2.06 B USD | 26.30 USD | −0.59% | 423.1 K | 0.49 | 62.68 | 0.42 USD | — | 0.00% | Health technology | Buy |
 NAMSNewAmsterdam Pharma Company N.V. | 2.06 B USD | 18.33 USD | −0.03% | 342.14 K | 0.32 | — | −1.88 USD | −1,314.68% | 0.00% | Health technology | Strong buy |
 KNSAKiniksa Pharmaceuticals, Ltd. | 2.05 B USD | 28.12 USD | −0.93% | 140.16 K | 0.19 | — | −0.24 USD | −324.19% | 0.00% | Health technology | Strong buy |
 BCRXBioCryst Pharmaceuticals, Inc. | 2.02 B USD | 9.68 USD | −0.67% | 1.09 M | 0.32 | — | −0.26 USD | +75.79% | 0.00% | Health technology | Strong buy |
 CGONCG Oncology, Inc. | 1.96 B USD | 25.67 USD | −1.52% | 228.96 K | 0.29 | — | −1.39 USD | — | 0.00% | Health technology | Strong buy |
 AGIOAgios Pharmaceuticals, Inc. | 1.91 B USD | 33.03 USD | +0.96% | 101.1 K | 0.17 | 2.93 | 11.29 USD | — | 0.00% | Health technology | Buy |
 IDYAIDEAYA Biosciences, Inc. | 1.91 B USD | 21.80 USD | −0.95% | 546.47 K | 0.58 | — | −3.59 USD | −79.25% | 0.00% | Health technology | Strong buy |
 NVCRNovoCure Limited | 1.9 B USD | 17.06 USD | −1.53% | 291.82 K | 0.19 | — | −1.51 USD | +16.28% | 0.00% | Health technology | Buy |
 ADPTAdaptive Biotechnologies Corporation | 1.85 B USD | 12.15 USD | +1.42% | 2.52 M | 1.35 | — | −0.96 USD | +35.36% | 0.00% | Health technology | Strong buy |
 IRONDisc Medicine, Inc. | 1.84 B USD | 53.18 USD | −1.36% | 75.29 K | 0.18 | — | −3.93 USD | −16.23% | 0.00% | Health technology | Strong buy |
 GLPGGalapagos NVDR | 1.83 B USD | 28.05 USD | +1.24% | 52.58 K | 0.18 | — | −2.73 USD | +2.73% | 0.00% | Health technology | Neutral |
 HRMYHarmony Biosciences Holdings, Inc. | 1.83 B USD | 31.93 USD | +1.12% | 184.7 K | 0.28 | 12.17 | 2.62 USD | +13.25% | 0.00% | Health technology | Strong buy |
 CNTACentessa Pharmaceuticals plcDR | 1.79 B USD | 12.92 USD | −3.80% | 213.09 K | 0.18 | — | −1.80 USD | −26.97% | 0.00% | Health technology | Strong buy |
 SUPNSupernus Pharmaceuticals, Inc. | 1.76 B USD | 31.37 USD | +0.42% | 181.26 K | 0.21 | 28.40 | 1.10 USD | — | 0.00% | Health technology | Buy |
 SPRYARS Pharmaceuticals, Inc. | 1.73 B USD | 17.59 USD | +1.93% | 611.04 K | 0.45 | — | −0.16 USD | +68.69% | 0.00% | Health technology | Strong buy |
 FOLDAmicus Therapeutics, Inc. | 1.72 B USD | 5.58 USD | −1.41% | 1.1 M | 0.18 | — | −0.09 USD | +80.86% | 0.00% | Health technology | Strong buy |
 GRALGRAIL, Inc. | 1.72 B USD | 47.76 USD | +3.43% | 513.41 K | 0.45 | — | −60.80 USD | −26.63% | 0.00% | Health technology | Neutral |
 INDVIndivior PLC | 1.71 B USD | 13.68 USD | −0.36% | 220.55 K | 0.26 | — | −0.23 USD | −1,980.17% | 0.00% | Health technology | Strong buy |
 ARQTArcutis Biotherapeutics, Inc. | 1.7 B USD | 14.26 USD | −1.45% | 619.72 K | 0.28 | — | −1.04 USD | +64.22% | 0.00% | Health technology | Strong buy |
 BEAMBeam Therapeutics Inc. | 1.7 B USD | 16.89 USD | +0.78% | 620.71 K | 0.35 | — | −4.61 USD | −158.90% | 0.00% | Health technology | Strong buy |
 SRPTSarepta Therapeutics, Inc. | 1.68 B USD | 17.11 USD | −1.98% | 3.57 M | 0.32 | — | −2.58 USD | −3,975.64% | 0.00% | Health technology | Buy |
 TARSTarsus Pharmaceuticals, Inc. | 1.68 B USD | 39.91 USD | −0.72% | 121.33 K | 0.18 | — | −2.73 USD | +42.86% | 0.00% | Health technology | Strong buy |
 IMCRImmunocore Holdings plcDR | 1.61 B USD | 32.43 USD | +1.31% | 88.62 K | 0.17 | — | −0.44 USD | +63.69% | 0.00% | Health technology | Buy |
 VERAVera Therapeutics, Inc. | 1.46 B USD | 22.97 USD | −1.48% | 1.31 M | 0.84 | — | −3.00 USD | −46.70% | 0.00% | Health technology | Strong buy |
 OCULOcular Therapeutix, Inc. | 1.46 B USD | 9.19 USD | −0.01% | 794.99 K | 0.24 | — | −1.15 USD | +15.26% | 0.00% | Health technology | Strong buy |
 TXG10x Genomics, Inc. | 1.43 B USD | 11.49 USD | −1.46% | 2.53 M | 0.69 | — | −1.30 USD | +42.17% | 0.00% | Health technology | Buy |